Oragenics, Inc

OGENAMEX · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

4.51M

on 2026-06-30, from 149K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-30 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2026-01-22. None sold under it to 2026-10-05. S-3 ↗

7 of its filings are not read yet.

Warrants

678K

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

1.5 quarters

$3.9M on 2026-06-30 ÷ $2.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-07-02	Public offering	not read	not read	$16.5M	424B5 ↗

Also on file: a 1-for-30 reverse split, 2025-05-27 8-K ↗